Target intelligence / Profile preview

H-2 class I histocompatibility antigen, K-D alpha chain (H2-Kd)

Target
H2-Kd
Molecular classification
MHC class I, Immunoglobulin superfamily, Receptor
01

Overview

H-2 class I histocompatibility antigen, K-D alpha chain (H2-Kd) is a polymorphic protein belonging to the Major Histocompatibility Complex (MHC) class I family in mice, specifically found in the d-haplotype such as in BALB/c strains (UniProt: P01901). It functions as a heterodimer with beta-2 microglobulin to present short intracellular peptides, typically 8-10 amino acids in length, to the T-cell receptors (TCRs) of CD8+ cytotoxic T lymphocytes (Janeway's Immunobiology). On dendritic cells, H2-Kd is pivotal for the initiation of the adaptive immune response, as these cells are uniquely capable of cross-presenting exogenous antigens on MHC class I molecules to prime naive T cells (Nature, 1998, 392:245-252). This molecule is a cornerstone of preclinical immunology research, serving as a target for evaluating peptide vaccines, TCR-engineered T cells, and monoclonal antibodies in mouse models of cancer and infectious disease (J. Immunol., 2005, 174:6712-6719). Therapeutic strategies often focus on loading H2-Kd with specific tumor-associated or viral antigens to elicit a robust cellular immune response. However, targeting MHC molecules requires high specificity to avoid off-target autoimmune reactions or systemic inflammatory responses.

Other names
H-2K(d)H2-K1MHC class I antigen K-dMouse MHC class I H2-Kd
02

Mechanism of action

Presentation of intracellularly processed antigenic peptides to the T-cell receptor (TCR) of CD8+ cytotoxic T lymphocytes.

03

Biological functions

Antigen presentationImmune responseT cell activationCell-cell signaling
04

Disease associations

InfectionCancerAutoimmunity
05

Safety considerations

Autoimmune inductionOff-target T-cell activationImmune evasion via MHC downregulationCytokine release syndrome
06

Interacting drugs

Experimental peptide vaccines (e.g., AH1 peptide)

2 more in the full profile.

07

Biomarkers

Surface expression of H2-Kd on CD11c+ dendritic cellsMHC-peptide multimer bindingCD8+ T-cell activation markers (e.g., IFN-gamma, CD69)

Beyond the preview

Go deeper on H-2 class I histocompatibility antigen, K-D alpha chain (H2-Kd).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on H-2 class I histocompatibility antigen, K-D alpha chain (H2-Kd).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call